v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenues $ 768 $ 1,470 $ 3,517
Costs of revenues 1,553 1,508 1,283
Gross profit (loss) (785) (38) 2,234
Operating expenses:      
Research and development, net 35,091 34,082 36,731
Sales and marketing 5,430 5,194 4,621
General and administrative 8,347 7,571 8,613
Total operating expenses 48,868 46,847 49,965
Operating loss (49,653) (46,885) (47,731)
Financial income, net 336 3,385 7,237
Net loss $ (49,317) $ (43,500) $ (40,494)
Basic net loss per ordinary share (in Dollars per share) $ (0.61) $ (0.6) $ (0.64)
Weighted-average number of ordinary shares used in computing basic net loss per ordinary share (in Shares) 80,949,032 72,021,520 63,489,983
Diluted net loss per ordinary share (in Dollars per share) [1] $ (0.61) $ (0.61) $ (0.66)
Weighted-average number of ordinary shares used in computing diluted net loss per ordinary share (in Shares) 80,949,032 72,053,372 63,629,206
[1] Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company’s net loss for 2024, 2023 and 2022 as set forth in the following table.

Source